Shandong Jincheng Pharmaceutical and Chemical Co Ltd Strategic Asset Allocation Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd strategic asset allocation index. Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Strategic Asset Allocation Index of 65.3% as of June 2023. Strategic assets (PP&E of CN¥2.44 Billion plus long-term investments of CN¥-) total CN¥2.44 Billion, measured against net assets of CN¥3.73 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 300233 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2021)
Strategic asset allocation index of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2021. This chart shows how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of June 2023, the index stands at 65.3%, representing strategic assets of CN¥2.44 Billion against net assets of CN¥3.73 Billion CNY.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Strategic Asset Allocation Index by Year (2008–2021)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd strategic asset allocation index by year from 2008 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300233 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 60.8% | CN¥2.09 Billion | CN¥2.09 Billion | CN¥- | CN¥3.44 Billion | ▲ +9.6 pp |
| 2020 | 51.3% | CN¥1.78 Billion | CN¥1.78 Billion | CN¥- | CN¥3.47 Billion | ▲ +9.6 pp |
| 2019 | 41.7% | CN¥1.70 Billion | CN¥1.70 Billion | CN¥- | CN¥4.08 Billion | ▲ +2.2 pp |
| 2018 | 39.5% | CN¥1.61 Billion | CN¥1.50 Billion | CN¥117.33 Million | CN¥4.09 Billion | ▲ +4.3 pp |
| 2017 | 35.2% | CN¥1.39 Billion | CN¥1.33 Billion | CN¥60.96 Million | CN¥3.94 Billion | ▼ -24.7 pp |
| 2016 | 59.9% | CN¥900.61 Million | CN¥843.31 Million | CN¥57.30 Million | CN¥1.50 Billion | ▲ +0.2 pp |
| 2015 | 59.7% | CN¥781.91 Million | CN¥774.61 Million | CN¥7.30 Million | CN¥1.31 Billion | ▼ -8.9 pp |
| 2014 | 68.6% | CN¥766.02 Million | CN¥766.02 Million | CN¥- | CN¥1.12 Billion | ▼ -3.4 pp |
| 2013 | 72.0% | CN¥735.76 Million | CN¥735.76 Million | CN¥- | CN¥1.02 Billion | ▲ +10.4 pp |
| 2012 | 61.6% | CN¥600.89 Million | CN¥600.89 Million | CN¥- | CN¥975.57 Million | ▲ +4.0 pp |
| 2011 | 57.6% | CN¥552.04 Million | CN¥552.04 Million | CN¥- | CN¥958.84 Million | ▼ -64.9 pp |
| 2010 | 122.5% | CN¥459.85 Million | CN¥459.85 Million | CN¥- | CN¥375.33 Million | ▲ +6.2 pp |
| 2009 | 116.3% | CN¥327.50 Million | CN¥327.50 Million | CN¥- | CN¥281.53 Million | ▲ +26.5 pp |
| 2008 | 89.8% | CN¥194.41 Million | CN¥194.41 Million | CN¥- | CN¥216.49 Million | — |